Astera Labs (NASDAQ:ALAB) Issues Quarterly Earnings Results, Misses Expectations By $0.16 EPS

Astera Labs (NASDAQ:ALABGet Free Report) posted its quarterly earnings data on Monday. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.26 by ($0.16), Zacks reports. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. Astera Labs updated its Q1 2025 guidance to 0.280-0.290 EPS.

Astera Labs Stock Up 2.0 %

Shares of ALAB stock opened at $103.29 on Tuesday. The business’s fifty day simple moving average is $122.39 and its 200-day simple moving average is $82.15. Astera Labs has a 12-month low of $36.22 and a 12-month high of $147.39.

Insiders Place Their Bets

In related news, CEO Jitendra Mohan sold 171,064 shares of the company’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $103.53, for a total transaction of $17,710,255.92. Following the completion of the transaction, the chief executive officer now owns 628,895 shares in the company, valued at $65,109,499.35. This represents a 21.38 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Stefan A. Dyckerhoff sold 197,297 shares of the company’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $90.51, for a total transaction of $17,857,351.47. Following the transaction, the director now owns 6,148 shares of the company’s stock, valued at approximately $556,455.48. This trade represents a 96.98 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 846,452 shares of company stock worth $86,427,256.

Analyst Ratings Changes

Several brokerages have issued reports on ALAB. Barclays lifted their price target on Astera Labs from $87.00 to $135.00 and gave the stock an “overweight” rating in a research note on Friday, January 17th. JPMorgan Chase & Co. boosted their price target on Astera Labs from $70.00 to $110.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th. Northland Capmk upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 28th. Roth Mkm boosted their price target on Astera Labs from $80.00 to $105.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on Astera Labs from $60.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $107.42.

View Our Latest Stock Report on Astera Labs

About Astera Labs

(Get Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Recommended Stories

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.